Republic Technologies Engages Fireblocks to Bolster Institutional-Grade Risk Management

Republic Technologies Engages Fireblocks to Bolster Institutional-Grade Risk Management

Republic Technologies Inc. (CSE: DOCT,OTC:DOCKF) (FSE: 7FM0) (WKN: A41AYF) (the "Company" or "Republic") today announced a strategic engagement with Fireblocks, the enterprise platform trusted by over 2,200 organizations worldwide for secure digital asset custody and operations. The partnership will provide Republic with advanced custody, governance, and risk controls to safeguard its ETH-denominated treasury and support the commercialization of its attestation business.

Republic's attestation platform relies on Ethereum validators to issue and verify digital proofs across sectors such as compliance, financial services, and supply chain integrity. By onboarding Fireblocks, Republic gains access to multi-party computation (MPC) custody, hardware-backed key management, and policy-based governance engines that are already relied upon by leading banks, fintechs, and asset managers. These capabilities will enable Republic to deploy its treasury into validator operations while maintaining institutional-grade security and risk oversight.

This collaboration advances Republic's commercialization roadmap by embedding security and risk management into the core of its business operations. Together, Republic and Fireblocks aim to set a new benchmark for secure, compliant, and scalable Ethereum-based infrastructure serving institutional markets.

About Republic Technologies Inc.

Republic Technologies is a publicly traded technology company integrating Ethereum infrastructure into the global economy. Backed by an ETH-denominated treasury, we operate proprietary validator and attestation networks to safeguard data integrity for universal applications.

On behalf of the Board of Directors
Daniel Liu, Chief Executive Officer
Email: daniel@republictech.io
https://republictech.io/

Neither the Canadian Securities Exchange nor its Regulation Services Provider has reviewed or accepts responsibility for the accuracy or adequacy of this release.

FORWARD-LOOKING STATEMENTS

This press release contains "forward-looking information" and "forward-looking statements" within the meaning of applicable securities legislation (collectively, "forward-looking statements"). Forward-looking statements herein are made as of the date of this press release only, and the Company does not undertake any obligation to update or revise them to reflect new information, estimates, opinions, future events, or results, except as required by applicable law. Forward-looking statements are often, but not always, identified by the use of words such as "plans," "expects," "is expected," "budgets," "scheduled," "estimates," "forecasts," "predicts," "projects," "intends," "targets," "aims," "anticipates," or "believes," or variations (including negative variations) of such words and phrases, or by statements that certain actions, events, or results "may," "could," "should," "would," "might," or "will" occur.

These forward-looking statements include, among other things, statements regarding: the anticipated benefits and outcomes of the Company's engagement with Fireblocks, including the enhancement of governance, custody, and risk management; the development, scalability, and commercialization of the Company's attestation platform; the anticipated applications and benefits of Ethereum-based infrastructure; and the ability of the Company to achieve institutional-grade standards in its treasury and validator operations.

Forward-looking statements are based on a number of assumptions, including, without limitation, that the Company will successfully integrate Fireblocks' platform, that its attestation platform will perform as anticipated, that Ethereum-based infrastructure will continue to be adopted by enterprises and institutions, and that the Company will be able to execute on its commercialization roadmap as planned.

Forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause the actual results, performance, or achievements of the Company to differ materially from those expressed or implied by such statements. These risks include, without limitation, the risk that the Company will be unable to realize the anticipated benefits of its engagement with Fireblocks, that the Company's attestation platform may not be successfully developed or commercially deployed, that market or regulatory conditions may not evolve as expected, or that the Company may be unable to scale its operations in line with institutional standards.

The forward-looking statements contained in this press release represent management's best judgment based on information available at the time of release. No forward-looking statement can be guaranteed, and actual results may vary materially. Readers are cautioned not to place undue reliance on forward-looking statements. Neither the Company nor any of its representatives make any representation or warranty, express or implied, as to the accuracy, sufficiency, or completeness of the information in this press release, and neither the Company nor its representatives shall have any liability whatsoever arising from the use of this press release or reliance on the information contained herein.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/267114

News Provided by Newsfile via QuoteMedia

DOCT:CNX
The Conversation (0)
beyond medical

Beyond Medical Technologies

Keeping Canadians Healthy and Safe

Keeping Canadians Healthy and Safe Keep Reading...
Scientists working in a modern medical research laboratory.

Pathways to Commercialising Biotech Innovations

In the medical technology industry, innovation is only the first step. While key to long-term success, innovation is only as good as a company’s commercialisation strategy. Once a technology has been developed and proven, the organisation must then embark on a process to commercialise it for... Keep Reading...
HeraMED Signs Strategic Collaboration Agreement with Garmin Health

HeraMED Signs Strategic Collaboration Agreement with Garmin Health

HeraMED Limited (ASX: HMD), a medical data and technology company leading the digital transformation of maternity care, is delighted to announce it has entered into a collaboration agreement with Garmin (NYSE: GRMN), a leading global provider of smartwatches and GPS-enabled products, aimed at... Keep Reading...
Cyclomedica

Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

Cyclopharm Limited (ASX: CYC) is pleased to announce the signing of a major contract with Hospital Corporation of America Healthcare (HCA), one of the largest single healthcare providers in the United States. This agreement marks a significant milestone for the company which will allow the... Keep Reading...
CONNEQT App Launches in USA as Pulse Deliveries Commence

CONNEQT App Launches in USA as Pulse Deliveries Commence

Cardiex Limited (CDX:AU) has announced CONNEQT App Launches in USA as Pulse Deliveries CommenceDownload the PDF here. Keep Reading...
Female doctor with clipboard talking to smiling female patient at hospital.

Revolutionizing Women's Health: Antifungal Innovation Brings New Investment Opportunities

The intersection of women's health and antifungal innovation represents a pivotal moment in healthcare, offering both transformative medical advancements and compelling investment opportunities. The groundbreaking developments in antifungal treatments specifically targeting women's health issues... Keep Reading...
Zero Candida Technologies (TSXV:ZCT)

Zero Candida Announces Plans to Complete Preclinical Studies for FDA Submission by Q3 2025

Zero Candida Technologies, Inc. (TSXV: ZCT), (FSE: 9L2) (the "Company" or "ZCT"), an Israeli FemTech medical device company focused on revolutionizing women's health, announces plans to complete preclinical studies for FDA submission by Q3 2025. In accordance with FDA requirements, the company... Keep Reading...

Interactive Chart

Latest Press Releases

Related News